Company Overview
See Details
About

GEMA Biotech is an Argentine biotechnology company specializing in the development, production, and commercialization of recombinant protein medicines, along with a line of special treatments. Founded in 1998, it initially focused on basic research in molecular biology before refocusing on biotech drug development in 2005 as a member of AMEGA Biotech, and is a Megalabs company. It operates state-of-the-art production plants in Santa Fe and Buenos Aires, with an integrated value chain from cell engineering to finished product under GMP standards. The company was a regional pioneer, launching the first biosimilar of Etanercept in the region in 2019, and maintains a global presence across the Americas, Europe, Asia, and Africa.

Trade Profile
Import Export
Trade Records 126
Trade Records 136
Suppliers -
Buyers -
Latest Import Date 2026-06
Latest Export Date 2026-06
Source: Topease Global Trade Data
Export Profile

According to Topease's global trade data, GEMABIOTECH S A exports products to verified importers across global markets.

Its export activity is associated with HS-code categories such as:

Import Profile

As an importer, GEMABIOTECH S A sources products from verified exporters across multiple regions.

Its import activity spans HS-code categories including:

Unlock Trade Network
Import Data
Full Analysis

Explore GEMABIOTECH S A's import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.

Import Trend
Top Imported HS Codes
Export Data
Full Analysis

Gain insights into GEMABIOTECH S A's export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.

Export Trend
Top Exported HS Codes
Key Contact Details
View Business Contact Details

Access GEMABIOTECH S A's key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.

XB
X. B.
Director
Phone LinkedIn
ML
M. L. C.
R&D Vice Director
Phone LinkedIn
NO
N. O.
Analista de compras
Phone LinkedIn
JF
J. F.
Jefe De Logistica Y Deposito,Supply Chain Manager
Phone LinkedIn
PR
P. R. M.
Propietario de empresa pequeña
Phone LinkedIn
JM
J. M.
Jefe de ventas
Phone LinkedIn
Is GEMABIOTECH S A the Right Trade Partner For You?
Topease helps you evaluate real trade activity, sourcing behavior, and global market presence in minutes—not months.
Verified Trade Activity
See GEMABIOTECH S A's shipment history, HS-code product mix, sourcing regions, and trading partners based on verified global customs data.
View Full Trade Activity
Procurement Signals
Identify when GEMABIOTECH S A is actively purchasing, how frequently it imports, and which suppliers it relies on—powered by shipment-level timelines.
Explore Procurement Signals
Price & Volume Insights
Access product-level import and export values to benchmark pricing, assess demand, and understand purchasing patterns.
Access Price & Volume Data
Decision-Maker Access
Reach verified procurement and supply-chain contacts with direct email, phone, and LinkedIn profiles to accelerate your outreach.
See Verified Contacts
Competitors of GEMABIOTECH S A
Compare GEMABIOTECH S A with its competitors to evaluate its position in the market. Through Topease's competitor analysis, users can assess how closely other companies align in product focus, market reach, and trade-network behavior—revealing competitive pressure, strategic gaps, and potential areas for growth.
Powered by Topease global trade data covering 232 countries. Access verified customs records, import/export activity, supply chain insights and decision-maker contacts for smarter global growth expansion.
Explore More Companies

Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.